-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 10.1%
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 10.1%
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) saw a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 2,660,000 shares, a drop of 10.1% from the December 15th total of 2,960,000 shares. Currently, 5.5% of the shares of the company are short sold. Based on an average daily volume of 278,500 shares, the days-to-cover ratio is presently 9.6 days.
Hyperfine Trading Up 5.6 %
HYPR stock opened at $0.95 on Friday. The firm has a 50 day moving average of $0.84 and a 200-day moving average of $1.12. Hyperfine has a 12-month low of $0.68 and a 12-month high of $5.20.
Get Hyperfine alerts:Hyperfine (NASDAQ:HYPR – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.26) by $0.07. Hyperfine had a negative net margin of 1,479.40% and a negative return on equity of 54.01%. The company had revenue of $2.35 million during the quarter, compared to the consensus estimate of $1.60 million. Sell-side analysts forecast that Hyperfine will post -1.1 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CMO Khan Siddiqui sold 1,039 shares of the firm's stock in a transaction dated Wednesday, November 16th. The stock was sold at an average price of $84.00, for a total transaction of $87,276.00. Following the transaction, the chief marketing officer now owns 85,080 shares of the company's stock, valued at $7,146,720. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Hyperfine news, Director Jonathan M. Rothberg acquired 47,007 shares of the stock in a transaction on Tuesday, November 29th. The shares were bought at an average price of $0.72 per share, with a total value of $33,845.04. Following the acquisition, the director now owns 656,492 shares of the company's stock, valued at $472,674.24. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Khan Siddiqui sold 1,039 shares of Hyperfine stock in a transaction that occurred on Wednesday, November 16th. The shares were sold at an average price of $84.00, for a total value of $87,276.00. Following the completion of the sale, the chief marketing officer now directly owns 85,080 shares in the company, valued at approximately $7,146,720. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 86,495 shares of company stock valued at $69,289 and have sold 5,161 shares valued at $90,738. Corporate insiders own 26.11% of the company's stock.Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of HYPR. Security Benefit Life Insurance Co. KS acquired a new position in shares of Hyperfine during the 3rd quarter worth approximately $2,025,000. Vanguard Group Inc. acquired a new position in Hyperfine in the 1st quarter valued at $6,237,000. Alphabet Inc. acquired a new position in Hyperfine in the 3rd quarter valued at $728,000. BlackRock Inc. acquired a new position in Hyperfine in the 1st quarter valued at $2,042,000. Finally, State Street Corp acquired a new position in Hyperfine in the 1st quarter valued at $378,000. 27.65% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, B. Riley began coverage on Hyperfine in a report on Tuesday, October 4th. They issued a "buy" rating and a $3.50 price objective on the stock.
About Hyperfine
(Get Rating)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings.
Featured Stories
- Get a free copy of the StockNews.com research report on Hyperfine (HYPR)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) saw a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 2,660,000 shares, a drop of 10.1% from the December 15th total of 2,960,000 shares. Currently, 5.5% of the shares of the company are short sold. Based on an average daily volume of 278,500 shares, the days-to-cover ratio is presently 9.6 days.
空頭股數(納斯達克代碼：HYPR-GET Rating)12月份空頭股數銷量大幅下降。截至12月30日，空頭股數共有266萬股，與12月15日的296萬股相比，下降了10.1%。目前，該公司5.5%的股份被賣空。以日均成交量27.85萬股計算，目前天數與回補比率為9.6天。
Hyperfine Trading Up 5.6 %
超精細交易上漲5.6%
HYPR stock opened at $0.95 on Friday. The firm has a 50 day moving average of $0.84 and a 200-day moving average of $1.12. Hyperfine has a 12-month low of $0.68 and a 12-month high of $5.20.
上週五，HYPR的股價開盤報0.95美元。該公司的50日移動均線切入位在0.84美元，200日移動均線切入位在1.12美元。超級罰款為0.68美元，為12個月低點，12個月高位為5.20美元。
Hyperfine (NASDAQ:HYPR – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.26) by $0.07. Hyperfine had a negative net margin of 1,479.40% and a negative return on equity of 54.01%. The company had revenue of $2.35 million during the quarter, compared to the consensus estimate of $1.60 million. Sell-side analysts forecast that Hyperfine will post -1.1 earnings per share for the current fiscal year.
超精細(納斯達克：HYPR-GET Rating)上一次公佈季度收益是在11月10日星期四。該公司公佈本季度每股收益(EPS)為0.19美元，比分析師普遍預期的0.26美元高出0.07美元。超級罰款的淨利潤率為負1,479.40%，淨資產回報率為負54.01%。該公司本季度營收為235萬美元，而市場普遍預期為160萬美元。賣方分析師預測，超罰款將公佈本財年的每股收益為1.1美元。
Insiders Place Their Bets
內部人士下注
Institutional Inflows and Outflows
機構資金流入和流出
Several institutional investors have recently modified their holdings of HYPR. Security Benefit Life Insurance Co. KS acquired a new position in shares of Hyperfine during the 3rd quarter worth approximately $2,025,000. Vanguard Group Inc. acquired a new position in Hyperfine in the 1st quarter valued at $6,237,000. Alphabet Inc. acquired a new position in Hyperfine in the 3rd quarter valued at $728,000. BlackRock Inc. acquired a new position in Hyperfine in the 1st quarter valued at $2,042,000. Finally, State Street Corp acquired a new position in Hyperfine in the 1st quarter valued at $378,000. 27.65% of the stock is currently owned by institutional investors and hedge funds.
幾家機構投資者最近調整了對HYPR的持股。安全福利人壽保險公司KS在第三季度收購了價值約2,025,000美元的超級罰款股票的新頭寸。先鋒集團(Vanguard Group Inc.)在第一季度收購了一個新的超罰款頭寸，估值為6,237,000美元。Alphabet在第三季度收購了價值728,000美元的超級罰款新頭寸。貝萊德股份有限公司在第一季度獲得了一個新的超級罰款頭寸，估值為2,042,000美元。最後，道富集團在第一季度獲得了一個新的超罰款頭寸，估值為37.8萬美元。27.65%的股票目前由機構投資者和對衝基金持有。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Separately, B. Riley began coverage on Hyperfine in a report on Tuesday, October 4th. They issued a "buy" rating and a $3.50 price objective on the stock.
另外，B.萊利在10月4日星期二的一份報告中開始報道超級罰款。他們對該股的評級為“買入”，目標價為3.5美元。
About Hyperfine
關於超精細
(Get Rating)
(獲取評級)
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings.
Hyperfiny，Inc.是一家醫療設備公司，提供磁共振成像(MRI)產品。該公司的產品包括Swoop便攜式磁共振成像系統，該系統在護理點提供神經成像，並在廣泛的臨牀環境中及時診斷和治療急性疾病。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Hyperfine (HYPR)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 免費獲取StockNews.com關於超精細的研究報告(HYPR)
- 市場回顧周-1/16-1/20
- Old Dominion是否表明Trucking正在踩剎車？
- 諾德斯特龍對零售業降價的擔憂
- 埃克森美孚股票：在Buy Point附近
- 高股息率的必和必拓認為中國推動了23年的增長
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
接受超精品日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Hyperfining及相關公司評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧